Negative publicity over 10-K causes dip in Imnet revenues

Article

Negative publicity over 10-K causes dip in Imnet revenuesInformation systems developer Imnet Systems felt the effects of a delay in filing its year-end documents; the Atlanta-based vendor reported a 17% decrease in revenue for its 1998 fiscal

Negative publicity over 10-K causes dip in Imnet revenues

Information systems developer Imnet Systems felt the effects of a delay in filing its year-end documents; the Atlanta-based vendor reported a 17% decrease in revenue for its 1998 fiscal first quarter.

For the period (end-September), Imnet had revenues of $8 million, compared with $9.7 million in the 1997 fiscal first quarter. Imnet posted a loss of $3.1 million, compared with earnings before non-recurring charges of $1.4 million in the same period last year. The company's backlog grew by $2.7 million to $53.7 million.

Chairman and CEO Kenneth Rardin attributed the figures to the company's inability to complete several significant new and add-on contracts due to negative publicity surrounding the delay in filing its 10-K. He said the company is unlikely to make up the revenue shortfall in the remaining nine months of the fiscal year.

After delaying the filing to allow its auditor KPMG Peat Marwick to complete the company's audit (PNN 10/97), Imnet filed its 10-K with the Securities Exchange Commission on Oct. 6 with no material adjustments made to its previously announced results.

Recent Videos
SNMMI: Emerging PET Insights on Neuroinflammation with Progressive Apraxia of Speech (PAOS) and Parkinson-Plus Syndrome
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
Related Content
© 2025 MJH Life Sciences

All rights reserved.